BUPIVACAINE HYDROCHLORIDE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Contract SPE2DP26F8859 is a firm-fixed-price delivery order issued by the Defense Logistics Agency under parent contract SPE2DX25D9900. Awarded on August 9, 2026, to DMS Pharmaceutical Group Inc (CAGE 1UNB0), the contract is for the procurement of one package of Bupivacaine Hydrochloride Injection (NSN 6505011277946) for a total price of $26.40. The pharmaceutical product, manufactured by Fresenius Kabi USA, LLC, is classified under NAICS code 325412. The delivery is scheduled for August 24, 2026, with a destination of Fort Bragg, NC. Terms are FOB Destination, meaning the contractor is responsible for all transportation costs, and both inspection and acceptance will occur at the delivery point. Due to the nature of the medical supply, the contractor must use the fastest traceable shipping means, and the use of parcel post is strictly prohibited. There is zero tolerance for quantity variance on this order.
General Info
Contract Value
$26.4Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
